Jefferies is serving as lead financial advisor to International Paper (NYSE: IP; LSE: IPC) on their announced spin-off of EMEA Packaging Business; separation creates two independent, publicly traded companies: International Paper in North America (including legacy IP and DS Smith assets) and EMEA Packaging (comprising legacy DS Smith and IP assets in EMEA). The separation will create two independent regional public companies (North America and EMEA) each with focused management teams and business models, tailored investment and capital allocation strategies, and compelling financial profiles. This transaction reinforces Jefferies' leadership and continued momentum in advising public industrial companies on transformational transactions.
Jefferies
Investment Banking
New York City, New York 605,875 followers
Jefferies, the global investment banking firm serving clients for more than 60 years.
About us
Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com.
- Website
-
http://Jefferies.com
External link for Jefferies
- Industry
- Investment Banking
- Company size
- 5,001-10,000 employees
- Headquarters
- New York City, New York
- Type
- Public Company
- Founded
- 1962
- Specialties
- Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services
Locations
Employees at Jefferies
Updates
-
Jefferies is pleased to have served as Financial Advisor to Precision Aviation Group, a leading provider of aviation aftermarket distribution and repair services and portfolio company of GenNx360 Capital Partners, on its sale to VSE Corporation. This successful transaction further solidifies Jefferies’ position as a leading aerospace investment bank within the aftermarket and aviation services sector, particularly in advising complex transactions with strategic parties.
-
-
Jefferies is proud to have hosted 2026's first event in London as part of its ongoing Shareholder Engagement Series – The Rise of the Retail Investor: Trends, Tools & Transformation. The event was opened by Julian Roberts, Equity Research Analyst, Jefferies, and Shaun Yates, Direct to Consumer Strategy Director, AJ Bell, followed by an overview of successful private wealth engagement by Gareth Price, IR of LondonMetric Property plc. Our panelists then shared perspectives from within inside private wealth, where we heard from James Burns and Esther Gilbert. Finally, Marc Downes, James Deal and Simon Courtenay shared a summary of their tools in the marketplace.
-
Jefferies is pleased to have acted as Joint Global Coordinator on the $4.5 billion IPO of CSG, a leading global defense company based in the Czech Republic and listed on Euronext Amsterdam with a market cap of €25 billion. CSG is the largest European IPO since 2022, the second largest since 2018, and the largest ever Defense IPO globally. This transaction solidifies Jefferies' market leadership in the Aerospace & Defense sector and in European Equity Capital Markets.
-
-
Jefferies is pleased to have served as Exclusive Financial Advisor to Nathan's Famous, Inc. on its sale to Smithfield Foods, Inc. at a total enterprise value of approximately $450 million. The transaction secures Smithfield's perpetual rights to an iconic 100-year old brand with durable momentum in the attractive protein category, supporting continued expansion across both retail and foodservice channels. This transaction underscores Jefferies' leadership in advising category-defining consumer brands and our role as a trusted, long-term partner to public companies navigating their most important strategic decisions.
-
-
Jefferies Private Capital Advisory has released the latest version of their Global Secondary Market Review, reporting that the global secondary market once again broke volume records in 2025. Volume surged to a record $240 billion, representing a 48% YoY increase, made up of $125 billion of LP volume and $115 billion of GP-led volume. Substantial buyside demand, driven by an influx of new market entrants and increasing levels of dedicated secondary capital, was matched with robust supply of both LP portfolios and GP-led opportunities as active portfolio management and the desire for accelerated liquidity remained strategic priorities. Read more about the secondaries market in the full report: http://spklr.io/60428fOjg
-
2025 was an exceptionally active and successful year for the Jefferies UK & Ireland Investment Banking team. We are proud to have delivered on a number of high-profile UK public M&A transactions and secured several flagship corporate broking mandates, reinforcing our position as a trusted partner to our clients. A defining theme last year was the unprecedented consolidation within the UK Investment Funds sector. Jefferies advised on the most significant transactions in this space – and in prior years – underscoring our market-leading expertise. We also saw a marked increase in competitive public offers. Jefferies acted on four of the six contested UK public bids in 2025, more than any other adviser, highlighting the strength and depth of our capabilities in complex situations. Our commitment to excellence continues to be recognised externally, with strong performance in the latest Extel rankings – a testament to the quality of our research and the depth of our client relationships. Corporate access remains a key differentiator for Jefferies, with robust engagement across investor events and bespoke management roadshows throughout the year. On behalf of the Jefferies UK & Ireland Investment Banking team, we would like to thank you for your continued partnership in 2026.
-
Jefferies is pleased to have served as exclusive financial advisor to Symprove, the UK's number 1 probiotic and most recommended by healthcare practitioners, in its sale to Metagenics, a US-based global Consumer Health platform. This transaction exemplifies Jefferies' leading Consumer Health practice and our commitment to working with best-in-class clinical brands from around the world.
-
-
The 2026 Developed Europe Extel Survey is now open! Jefferies Research Analysts help clients stay ahead with timely insight and deep analysis in a rapidly evolving market landscape. Show your support for their expertise by awarding our team 5-star ratings! Vote Today: https://lnkd.in/e8tYqBpA
-
-
Over the past five years Jefferies has progressed in every region to become a Top 5 global provider of equity research, as recognized by Extel in 2025. With over 300 analysts covering 3,600+ stocks across the Americas, Europe, and Asia, we have never been more global. Thank you to all of our clients for their support from around the world, and congratulations to the team. The first survey of 2026 starts next week in Europe. For more information on how to vote, click below. http://spklr.io/60498LXuN